Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.
about
Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerThe Pathophysiological Impact of HLA Class Ia and HLA-G Expression and Regulatory T Cells in Malignant Melanoma: A ReviewHLA-G expression is an independent predictor for improved survival in high grade ovarian carcinomasCase-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.HLA-G impairs host immune response and predicts poor prognosis in pancreatic cancerHLA-G expression in cancers: roles in immune evasion, metastasis and target for therapyHuman leukocyte antigen-G is frequently expressed in glioblastoma and may be induced in vitro by combined 5-aza-2'-deoxycytidine and interferon-γ treatments: results from a multicentric study.Immune cell infiltration patterns and survival in head and neck squamous cell carcinomaMolecular alterations and clinical relevance in esophageal squamous cell carcinoma.The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases.Cancer treatment and the KIR-HLA system: an overview.High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.Human leukocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment.Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
P2860
Q26996829-1B6A08E6-CB37-4E6C-8CCC-1FA8BBC97782Q28080338-36373650-5E08-4078-BB5D-E1E555A9CC86Q33758727-0478CD61-C2E4-4210-9BA7-A5BB1C62FC9BQ34522328-6AE34BEF-38BB-421D-9F76-6308C7F24826Q35390989-1A59F53C-C137-49CA-A85D-A6F64DFF69ACQ36309539-A7D665F2-E454-4BCC-BEB5-63CAF3BCBE31Q36568297-D1F76D42-B023-4F78-8336-AEFFD4A3A66EQ36582874-CC16880B-FF41-439C-943A-2EB54CB8E0F7Q37692604-5FF67114-7902-46AC-9E58-EDDFE5C72609Q38134029-E9E6784B-0474-40FF-A47C-67F31575E4D7Q38362617-92E57971-CD71-4260-9C64-48A427C5E642Q39131056-B0B8370F-4B6F-4895-93C2-F4922CD69030Q41076095-D6A5DE1B-85A0-46F5-989F-2B2E821F51A4Q48199480-2E596F74-CFBA-440D-B9E7-C3D933C5AE1AQ49335253-409D59E8-AE23-41B3-B92F-7FAD7498EB26Q57490851-5A2E8EB2-54CB-493E-8EA9-7B120568366B
P2860
Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Human leukocyte antigen-G expr ...... ageal squamous cell carcinoma.
@en
Human leukocyte antigen-G expr ...... ageal squamous cell carcinoma.
@nl
type
label
Human leukocyte antigen-G expr ...... ageal squamous cell carcinoma.
@en
Human leukocyte antigen-G expr ...... ageal squamous cell carcinoma.
@nl
prefLabel
Human leukocyte antigen-G expr ...... ageal squamous cell carcinoma.
@en
Human leukocyte antigen-G expr ...... ageal squamous cell carcinoma.
@nl
P2093
P2860
P356
P1476
Human leukocyte antigen-G expr ...... ageal squamous cell carcinoma.
@en
P2093
Dan-Ping Xu
Wei-Hua Yan
Wen-Jun Zhou
Yan-Yun Ruan
P2860
P304
P356
10.1002/IJC.25807
P577
2011-02-26T00:00:00Z